Percutaneous Balloon Versus Surgical Closed and Open Mitral Commissurotomy

Author:

Farhat Mohamed Ben1,Ayari Mokdad1,Maatouk Faouzi1,Betbout Fethi1,Gamra Habib1,Jarrar Mourad1,Tiss Mabrouk1,Hammami Sonia1,Thaalbi Rafik1,Addad Faouzi1

Affiliation:

1. From the Division of Cardiology, Department of Medicine, Fattouma Bourguiba University Hospital, Tunisia.

Abstract

Background —Percutaneous balloon mitral commissurotomy (BMC) has been proposed as an alternative to surgical closed mitral commissurotomy (CMC) and open mitral commissurotomy (OMC) for the management of rheumatic mitral valve stenosis (MS). Methods and Results —We conducted a prospective, randomized trial comparing the results of the 3 procedures in 90 patients (30 patients in each group) with severe pliable MS. Cardiac catheterization was performed in all patients before and at 6 months after each procedure. All patients had clinical and echocardiographic evaluation initially and throughout the 7-year follow-up period. Gorlin mitral valve area (MVA) increased much more after BMC (from 0.9±0.16 to 2.2±0.4 cm 2 ) and OMC (from 0.9±0.2 to 2.2±0.4 cm 2 ) than after CMC (from 0.9±0.2 to 1.6±0.4 cm 2 ). Residual MS (MVA <1.5 cm 2 ) was 0% after BMC or OMC and 27% after CMC. There was no early or late mortality or thromboembolism among the three groups. At 7-year follow-up, echocardiographic MVA was similar and greater after BMC and OMC (1.8±0.4 cm 2 ) than after CMC (1.3±0.3 cm 2 ; P <.001). Restenosis (MVA <1.5 cm 2 ) rate was 6.6% after BMC or OMC versus 37% after CMC. Residual atrial septal defect was present in 2 patients and severe grade 3 mitral regurgitation was present in 1 patient in the BMC group. Eighty-seven percent of patients after BMC and 90% of patients after OMC were in New York Heart Association functional class I versus 33% ( P <.0001) after CMC. Freedom from reintervention was 90% after BMC, 93% after OMC, and 50% after CMC. Conclusions —In contrast to surgical CMC, BMC and OMC produce excellent and comparable early hemodynamic improvement and are associated with a lower rate of residual stenosis and restenosis and need for reintervention. However, the good results, lower cost, and elimination of drawbacks of thoracotomy and cardiopulmonary bypass indicate that BMC should be the treatment of choice for patients with tight pliable rheumatic MS.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 240 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Transcatheter Therapy for Mitral Valve Stenosis;Interventional Cardiology Clinics;2024-02

2. Outcomes of Severe Mitral Stenosis With the Revised Severity Criteria: Mitral Valve Replacement vs Percutaneous Mitral Valvuloplasty;Canadian Journal of Cardiology;2024-01

3. Echocardiography Assessment of Rheumatic Heart Disease: Implications for Percutaneous Balloon Mitral Valvuloplasty;Current Problems in Cardiology;2023-12

4. Kardiyovaskuler Islemlerde Goruntuleme;Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology;2022-12-20

5. Current status of adult cardiac surgery—Part 1;Current Problems in Surgery;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3